|
Adverse Outcome Pathways
|
E05.599.395.040 |
|
|
Broad Ligament
|
A02.513.170 |
|
|
Hyperargininemia
|
C18.452.648.189.937.437 |
|
|
Gonadal Dysgenesis, Mixed
|
C13.351.875.253.309.391 |
|
|
Body Remains
|
C23.550.260.127 |
|
|
Quinapril
|
D03.633.100.531.820.250 |
|
|
Tetrahydroisoquinolines
|
D03.633.100.531.820 |
|
|
Axonal Transport
|
G04.392.040 |
|
|
Cytoplasmic Streaming
|
G04.392 |
|
|
Renal Veins
|
A07.015.908.752 |
|
|
Heptanoic Acids
|
D006538 |
[7-carbon saturated monocarboxylic acids.
] |
|
Veratrum
|
B01.650.940.800.575.912.250.618.875.625.920 |
|
|
Heptoses
|
D006539 |
|
|
Sclera
|
A09.371.784 |
|
|
Heptachlor Epoxide
|
D006534 |
[An oxidation product of HEPTACHLOR formed by many plants and animals, including humans, after exposure to HEPTACHLOR. It has been shown to remain in soil treated with HEPTACHLOR for over fifteen years and is toxic to animals and humans. (From ATSDR Public Heath Statement, April 1989)
] |
|
Shellfish Proteins
|
D000078582 |
[Proteins found in SHELLFISH.
] |
|
Heptaminol
|
D006535 |
[An amino alcohol that has been used as a myocardial stimulant and vasodilator and to relieve bronchospasm. Its most common therapeutic use is in orthostatic hypotension. The mechanism of heptaminol's therapeutic actions is not well understood although it has been suggested to affect catecholamine release or calcium metabolism.
] |
|
Biobibliography
|
V01.165.150 |
|
|
Bibliography
|
V01.165 |
|
|
AMP-Activated Protein Kinases
|
D12.644.360.062 |
|
